|
Relsys' Industry Advisory Committee guides the development of the Argus Safety™ suite of products. The Committee is made up of experts from the Pharmaceutical Industry who are the leaders in their respective fields. Their contributions afford Relsys the opportunity to maintain its worldwide industry leadership.
| ADVISOR |
CURRENT AFFILIATION |
EXPERTISE |
| Felix Arellano MD, Dip Pharm Med, FISPE |
Risk Management Resources, LLC, Managing Partner |
PV, Risk Management |
| Mark K. Blake |
Boehringer-Ingelheim, Director Safety Operations; ex Astra Zeneca |
E2B, PSUR & Productivity |
| Elliot G. Brown, MB ChB, BMedSci (Hons), MRCGP, DipPharmMed, FFPM |
Director, Elliot Brown [Consulting] Ltd., EBT Ltd. |
MCA, MedDRA |
| Win Castle, MD, Ph.D. |
Retired with 20 yrs. Drug Safety experience: Astra Zeneca, Glaxo & Smith Kline Beecham |
Vision |
| Rosalind Coulson, PhC |
Consultant in Pharmacovigilance Information Management |
European Regulatory Advisor |
James Nickas, Pharm. D.
|
Genentech, Head, Drug Safety & GCP QA |
Vision, Product Direction |
| Monica Pietrek PhD, MD, MSc |
Pharmaceutical Research Associates, Director, Safety Management Services |
CRO & Product Direction |
| Vlasta Pinkston |
Glaxo Wellcome, Director, Safety Systems Management |
E2B, Risk Management, Product Direction |
| Valerie Simmons, MD |
Eli Lilly Co., Director-Global Pharmacovigilance |
Vision, Product Direction, PV & Risk Management |
|
日本語 | Home | Customer Login | Site Map 
